These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
451 related items for PubMed ID: 16776915
1. [The randomized study of efficiency and safety of antithrombotic therapy in nonvalvular atrial fibrillation: warfarin compared with aspirin]. Hu DY, Zhang HP, Sun YH, Jiang LQ, Antithrombotic Therapy in Atrial Fibrillation Study Group. Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Apr; 34(4):295-8. PubMed ID: 16776915 [Abstract] [Full Text] [Related]
5. Ximelagatran compared with warfarin for prevention of thromboembolism in patients with nonvalvular atrial fibrillation: Rationale, objectives, and design of a pair of clinical studies and baseline patient characteristics (SPORTIF III and V). Halperin JL, Executive Steering Committee, SPORTIF III and V Study Investigators. Am Heart J; 2003 Sep; 146(3):431-8. PubMed ID: 12947359 [Abstract] [Full Text] [Related]
8. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation. Hylek EM, Go AS, Chang Y, Jensvold NG, Henault LE, Selby JV, Singer DE. N Engl J Med; 2003 Sep 11; 349(11):1019-26. PubMed ID: 12968085 [Abstract] [Full Text] [Related]
9. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study. Jacobs LG, Billett HH, Freeman K, Dinglas C, Jumaquio L. Am J Geriatr Pharmacother; 2009 Jun 11; 7(3):159-66. PubMed ID: 19616184 [Abstract] [Full Text] [Related]
10. Anticoagulant prophylaxis against stroke in atrial fibrillation: effectiveness in actual practice. Caro JJ, Flegel KM, Orejuela ME, Kelley HE, Speckman JL, Migliaccio-Walle K. CMAJ; 1999 Sep 07; 161(5):493-7. PubMed ID: 10497604 [Abstract] [Full Text] [Related]
16. Anticoagulation therapy in Chinese patients with non-valvular atrial fibrillation: a prospective, multi-center, randomized, controlled study. Chen KP, Huang CX, Huang DJ, Cao KJ, Ma CS, Wang FZ, Zhang S. Chin Med J (Engl); 2012 Dec 15; 125(24):4355-60. PubMed ID: 23253701 [Abstract] [Full Text] [Related]
17. Atrial fibrillation, thromboembolism and antithrombotic therapy. Li-Saw-Hee FL, Lip GY. Int J Clin Pract; 1999 Mar 15; 53(2):110-7. PubMed ID: 10344046 [Abstract] [Full Text] [Related]
18. Stroke prevention in atrial fibrillation: pooled analysis of SPORTIF III and V trials. Albers GW, SPORTIF Investigators. Am J Manag Care; 2004 Dec 15; 10(14 Suppl):S462-9; discussion S469-73. PubMed ID: 15696910 [Abstract] [Full Text] [Related]
19. Rivaroxaban-once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation: rationale and design of the ROCKET AF study. ROCKET AF Study InvestigatorsDuke Clinical Research Institute, Durham, NC, USA.. Am Heart J; 2010 Mar 15; 159(3):340-347.e1. PubMed ID: 20211293 [Abstract] [Full Text] [Related]